Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2025-12-24 @ 6:47 PM
NCT ID:
NCT01050257
Eligibility Criteria:
Inclusion Criteria:
* Adult and adolescent patients, 13 years of age and older
* Diagnosis of influenza
* ≤ 144 hours between the onset of influenza-like illness and first dose of study drug
Non-randomized, open-label treatment group:
* Patients with moderate/severe renal impairment or renal failure with creatinine clearance 10-60 mL/min
Exclusion Criteria:
* Clinical evidence of severe hepatic decompensation at the time of randomization
* Acute ischemia or significant arrhythmia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Study:
NCT01050257
Study Brief:
Protocol Section:
NCT01050257